What?
www.csiro.au
In Australia it currently seems to be less frequent than the world average, appearing in only 50 per cent of the surveyed sequences (in 717 high quality isolates out of the total 1300 Australian isolates, 3rd May).
We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics. To date we have identified...
www.biorxiv.org
The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February